{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:27:03Z","timestamp":1789734423329,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1007\/s11940-002-0040-2","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T20:30:22Z","timestamp":1180989022000},"page":"231-237","source":"Crossref","is-referenced-by-count":20,"title":["Herpes simplex virus in children"],"prefix":"10.1007","volume":"4","author":[{"given":"Richard J.","family":"Whitley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"40_CR1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM199904223401608","volume":"340","author":"HH Balfour","year":"1999","unstructured":"Balfour HH, Jr: Antiviral drugs. N Engl J Med 1999, 340:1255\u20131268. Review of complete dosages of antiviral drugs.","journal-title":"N Engl J Med"},{"key":"40_CR2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","volume":"357","author":"RJ Whitley","year":"2001","unstructured":"Whitley RJ, Roizman B: Herpes simplex viruses: from structure to function. Lancet 2001, 357:1513.","journal-title":"Lancet"},{"key":"40_CR3","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1056\/NEJM199102143240703","volume":"324","author":"RJ Whitley","year":"1991","unstructured":"Whitley RJ, Arvin A, Prober C, et al.: A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N Engl J Med 1991, 324:444\u2013449. From 1991, the original controlled trial for antiviral therapy of neonatal herpes.","journal-title":"N Engl J Med"},{"key":"40_CR4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM199102143240704","volume":"324","author":"RJ Whitley","year":"1991","unstructured":"Whitley RJ, Arvin A, Prober C, et al.: Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991, 324:450\u2013454.","journal-title":"N Engl J Med"},{"key":"40_CR5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1542\/peds.108.2.230","volume":"108","author":"DW Kimberlin","year":"2001","unstructured":"Kimberlin DW, Lin C-Y, Jacobs RF, et al.: The safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001, 108:230\u2013238. The controlled study established the safety and efficacy of high-dose acyclovir for neonatal herpes simplex virus","journal-title":"Pediatrics"},{"key":"40_CR6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.108.2.223","volume":"108","author":"DW Kimberlin","year":"2001","unstructured":"Kimberlin DW, Lin C-Y, Jacobs RF, et al.: Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pedatrics 2001, 108:223\u2013229. Provides an update of improvement of neonatal herpes simplex virus management.","journal-title":"Pedatrics"},{"key":"40_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1056\/NEJM198601163140303","volume":"314","author":"RJ Whitley","year":"1986","unstructured":"Whitley RJ, Alford CA, Jr., Hirsch MS, et al.: Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986, 314:144\u2013149.","journal-title":"N Engl J Med"},{"key":"40_CR8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(84)92623-0","volume":"2","author":"B Skoldenberg","year":"1984","unstructured":"Skoldenberg B, Forsgren M, Alestig K, et al.: Acyclovir versus vidarabine in herpes simplex encephalitis: a randomized multicentre study in consecutive Swedish patients. Lancet 1984, 2:707\u2013711.","journal-title":"Lancet"},{"key":"40_CR9","unstructured":"Whitley RJ, Kimberlin D: Antiviral Agents. In Gellis and Kagan\u2019s Current Pediatric Therapy, vol 17. Edited by Burg FD, Ingelfinger JR, Polin RA, Gershon A. Philadelphia: WB Saunders; In press."},{"key":"40_CR10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2165\/00003495-200059040-00013","volume":"59","author":"D Ormrod","year":"2000","unstructured":"Ormrod D, Scott LJ, Perry CM: Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections. Drugs 2000, 59:839\u2013863.","journal-title":"Drugs"},{"key":"40_CR11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2165\/00003495-199652050-00009","volume":"52","author":"CM Perry","year":"1996","unstructured":"Perry CM, Faulds D: Valaciclovir: a review of its antiviral, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections. Drugs 1996, 52:754\u2013772.","journal-title":"Drugs"},{"key":"40_CR12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1086\/515385","volume":"178","author":"M Reitano","year":"1998","unstructured":"Reitano M, Tyring SK, Lang W, et al.: Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group. J Infect Dis 1998, 178:603\u2013610.","journal-title":"J Infect Dis"},{"key":"40_CR13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archderm.134.2.185","volume":"134","author":"SK Tyring","year":"1998","unstructured":"Tyring SK, Douglas JM, Jr., Corey L, et al.: A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Arch Dermatol 1998, 134:185\u2013191.","journal-title":"Arch Dermatol"},{"key":"40_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/09563202930040S602","volume":"4","author":"MA Pue","year":"1993","unstructured":"Pue MA, Benet LZ: Pharmacokinetics of famciclovir. Antiviral Chem Chemother 1993, 4(suppl):47\u201356.","journal-title":"Antiviral Chem Chemother"},{"key":"40_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-128-1-199801010-00004","volume":"128","author":"T Schacker","year":"1998","unstructured":"Schacker T, Hu HL, Koelle DM, et al.: Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons: a double blind, placebo-controlled trial. Ann Intern Med 1998, 128:21\u201328.","journal-title":"Ann Intern Med"},{"key":"40_CR16","first-page":"330","volume-title":"Infectious Diseases","author":"RJ Whitley","year":"1998","unstructured":"Whitley RJ: Antiviral Therapy. In Infectious Diseases, edn 2. Edited by Gorbach SL, Bartlett JG, Blacklow NR. Philadelphia: WB Saunders; 1998:330\u2013350.","edition":"edn 2"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-002-0040-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-002-0040-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-002-0040-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:46Z","timestamp":1559437006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-002-0040-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["40"],"URL":"https:\/\/doi.org\/10.1007\/s11940-002-0040-2","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}